Ignite Creation Date:
2025-12-25 @ 2:56 AM
Ignite Modification Date:
2025-12-26 @ 1:36 AM
Study NCT ID:
NCT04480333
Status:
UNKNOWN
Last Update Posted:
2020-07-21
First Post:
2020-07-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831
Sponsor:
Biomed Industries, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-07-13
First Submit QC Date:
None
Study First Post Date:
2020-07-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-16
Last Update Post Date:
2020-07-21
Last Update Post Date Type:
ACTUAL